Literature DB >> 27034819

Coexistence of intestinal Kaposi sarcoma and plasmablastic lymphoma in an HIV/AIDS patient: case report and review of the literature.

Bing Wang1, Bingbing Song1, Cyrus Oster1, Jeffery Cao1, Anwar Raza1, Jun Wang1.   

Abstract

Human immunodeficiency virus (HIV) infection or acquired immunodeficiency disease (AIDS) is associated with increased risk for various malignancies including Kaposi sarcoma (KS) and lymphoma. We report a rare case of coexistence of KS and plasmablastic lymphoma (PBL) in the gastrointestinal (GI) tract in a HIV/AIDS patient. A brief review of literature is also presented.

Entities:  

Keywords:  Human immunodeficiency virus (HIV); Kaposi sarcoma (KS); acquired immunodeficiency disease (AIDS); intestinal neoplasms; plasmablastic lymphoma (PBL)

Year:  2016        PMID： 27034819      PMCID： PMC4783623          DOI： 10.3978/j.issn.2078-6891.2015.021

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


  53 in total

Review 1.  Inflammatory reactivation and angiogenicity of Kaposi's sarcoma-associated herpesvirus/HHV8: a missing link in the pathogenesis of acquired immunodeficiency syndrome-associated Kaposi's sarcoma.

Authors:  E A Mesri
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

2.  HIV. One on one meets two.

Authors:  S Wain-Hobson
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

3.  Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma.

Authors:  Jorge J Castillo; Eric S Winer; Dariusz Stachurski; Kimberly Perez; Melhem Jabbour; Cannon Milani; Gerald Colvin; James N Butera
Journal:  Leuk Lymphoma       Date:  2010-10-04

4.  Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

Authors:  K M Kaye; K M Izumi; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

Review 5.  Human immunodeficiency virus-associated neoplasms: epidemiology, pathogenesis, and review of current therapy.

Authors:  D M Aboulafia
Journal:  Cancer Pract       Date:  1994 Jul-Aug

6.  Esophageal and gastric Kaposi's sarcomas presenting as upper gastrointestinal bleeding.

Authors:  Cheng-Hui Lin; Chao-Wei Hsu; Yan-Jen Chiang; Kwai-Fong Ng; Cheng-Tang Chiu
Journal:  Chang Gung Med J       Date:  2002-05

7.  Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma.

Authors:  Y Q Huang; J J Li; M H Kaplan; B Poiesz; E Katabira; W C Zhang; D Feiner; A E Friedman-Kien
Journal:  Lancet       Date:  1995-03-25       Impact factor: 79.321

Review 8.  HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.

Authors:  Jorge Castillo; Liron Pantanowitz; Bruce J Dezube
Journal:  Am J Hematol       Date:  2008-10       Impact factor: 10.047

9.  Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma.

Authors:  Toni Portis; Patricia Dyck; Richard Longnecker
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

10.  Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells.

Authors:  Cinzia Giagulli; Stefania Marsico; Anna K Magiera; Rosalinda Bruno; Francesca Caccuri; Ines Barone; Simona Fiorentini; Sebastiano Andò; Arnaldo Caruso
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240
View more
  2 in total

1.  Case report: dual primary AIDS-defining cancers in an HIV-infected patient receiving antiretroviral therapy: Burkitt's lymphoma and Kaposi's sarcoma.

Authors:  Seong Eun Kim; Younggon Jung; Tae Hoon Oh; Uh Jin Kim; Seung-Ji Kang; Hee-Chang Jang; Kyung-Hwa Park; Kyung-Hwa Lee; Sook In Jung
Journal:  BMC Cancer       Date:  2018-11-08       Impact factor: 4.430

2.  Kaposi's sarcoma manifested as lower gastrointestinal bleeding in a HIV/HBV-co-infected liver cirrhosis patient: A case report.

Authors:  Qi-Hui Zhou; Yong-Zheng Guo; Xia-Hong Dai; Biao Zhu
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.